scispace - formally typeset
X

Xiaozhong Guo

Researcher at Liaoning University of Traditional Chinese Medicine

Publications -  164
Citations -  3111

Xiaozhong Guo is an academic researcher from Liaoning University of Traditional Chinese Medicine. The author has contributed to research in topics: Cirrhosis & Portal vein thrombosis. The author has an hindex of 28, co-authored 142 publications receiving 2269 citations.

Papers
More filters
Journal ArticleDOI

Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.

TL;DR: A systematic review and meta-analysis aimed to compare the discriminative ability of Child–Pugh versus MELD score to assess the prognosis of cirrhotic patients and found that their benefits might be heterogeneous in some specific conditions.
Journal ArticleDOI

Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies

TL;DR: Anticoagulation could achieve a relatively high rate of portal vein recanalization in cirrhotic patients with PVT, given that only a small number of non-randomized comparative studies are reported, randomized controlled trials are warranted to confirm the risk-to-benefit of anticoagulant therapy in such patients.
Journal ArticleDOI

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis

TL;DR: APRI, AAR, FIB-4, Lok, and Forns scores had low to moderate diagnostic accuracy in predicting the presence of varices in liver cirrhosis.
Journal ArticleDOI

Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.

TL;DR: NLR should be a major prognostic factor for HCC patients and might be further incorporated into the prognostic model of HCC.
Journal ArticleDOI

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.

TL;DR: Abnormal liver biochemical tests are common in COVID-19 patients and are closely related to the severity and prognosis of patients, and non-survivors had a significantly higher incidence than survivors of abnormal liver biochemical indicators.